Last Updated: May 13, 2026

Litigation Details for Point.360, a California Corporation (Bankr. C.D. Cal. 2017)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Point.360, a California Corporation
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , and ⤷  Start Trial .

Details for Point.360, a California Corporation (Bankr. C.D. Cal. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-10-10 External link to document
2017-10-10 439 7,189,430 7,243,285 7,297,703 7,352,510 7,407,708 … (Where available) 60. Patents, copyrights, trademarks, and trade secrets 61 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Litigation Summary and Analysis for Point.360, a California Corporation | Case 2:17-bk-22432

Last updated: April 16, 2026

What Is the Nature of the Litigation Filed Against Point.360?

Point.360, a California-based corporate entity, is involved in bankruptcy proceedings under case number 2:17-bk-22432. The proceedings originated with an involuntary bankruptcy petition filed against the company, leading to its chapter 11 reorganization.

The case began with creditors asserting claims that financial obligations remained unpaid, prompting court intervention to protect creditors’ interests.

What Are the Key Litigation Events and Filings?

Filing Timeline and Major Motions

  • Initial Filing: In October 2017, creditors filed an involuntary petition under chapter 7, which was converted to chapter 11 in early 2018.
  • Automatic Stay: The filing triggered an automatic stay on all collection actions against the company.
  • Debt Disputes: Over the course of the case, disputes arose regarding the classification and priority of claims, notably between secured creditors and unsecured creditors.
  • Objections to Claims: Several creditors filed objections to the company's proposed plan of reorganization, demanding higher priority or liquidation of assets.

Court Orders and Adjudications

  • Asset Liquidation: The court approved the sale of some assets, including intellectual property rights, in 2019.
  • Reorganization Plan: The company proposed a plan in 2020, which faced objections from unsecured creditors claiming inadequate recoveries.
  • Plan Confirmation: The court confirmed the reorganization plan in December 2020, allowing the company to continue operations under court supervision.

Litigation Against Third Parties

  • Litigation Claims: Point.360 pursued claims against former executives regarding alleged misconduct that contributed to financial instability. These claims are ongoing, with court dates scheduled in 2023.
  • Preference Actions: The bankruptcy estate has initiated avoidance actions to recover preferential transfers made prior to filing, focusing on payments to creditors within 90 days before filing.

What Are the Legal Risks and Outcomes?

Potential for Litigation Losses

  • Disputes over claim priority threaten to increase liabilities if unsecured claims are reclassified.
  • Preference and fraudulent transfer actions could result in substantial recoveries owed back to the estate, reducing distributions to creditors.

Impact on Stakeholders

  • Creditors face uncertain recoveries, with unsecured claims potentially receiving less than expected.
  • Investors in the reorganized entity may experience diminished equity value depending on resolution of the parent company's liabilities.

Final Court Decisions

  • The bankruptcy court generally upholds the reorganization plan, but appeals could extend litigation timelines and costs.
  • Court rulings on preference recoveries and claims disputes could modify the creditor landscape significantly.

What Are the Implications for Industry and Market?

  • The case illustrates the risks faced by companies with significant intellectual property assets in bankruptcy.
  • It highlights the importance of robust claim management and dispute resolution strategies, especially concerning insider transactions and claims of misconduct.
  • The outcome may influence other bankruptcy cases involving intellectual property rights, particularly within the technology and media sectors.

What Is the Future Outlook for the Litigation?

  • The litigation surrounding claims and transfers continues, with key issues awaiting final court adjudication.
  • Pending appeals related to claim classifications could alter distributions.
  • Unresolved disputes with third-party defendants, such as former executives, may result in ongoing legal proceedings into 2024.

Key Takeaways

  • Point.360 filed for bankruptcy in 2017, with subsequent asset sales, claim disputes, and reorganization proceedings.
  • The company faces significant creditor claims, including objections to claims and preference actions.
  • Court approval of the reorganization plan in December 2020 established a framework for continuing operations.
  • Litigation involving third-party misconduct and claim priority remains active and unresolved.
  • The case exemplifies how complex bankruptcy litigation can impact company restructuring, creditor recoveries, and stakeholder interests.

FAQs

1. What triggered Point.360’s bankruptcy filing?
A combination of unpaid debts, creditor claims, and internal financial difficulties led to the involuntary bankruptcy petition in 2017.

2. What assets were sold during the bankruptcy process?
Intellectual property rights and other non-core assets were sold to satisfy creditor claims, with court approval in 2019.

3. How do preference actions affect creditors?
They allow the bankruptcy estate to recover payments made shortly before filing, potentially reducing distributions to unsecured creditors.

4. Are there ongoing litigation issues?
Yes, including disputes over claims, claim priorities, and allegations against former executives.

5. How might future legal rulings impact stakeholder recoveries?
Final decisions on claim classifications and preference recoveries could significantly alter creditor and investor payouts.


References

  1. In re Point.360, Case No. 2:17-bk-22432 (Bankr. C.D. Cal., 2017).
  2. Bankruptcy case docket and public filings from the U.S. Bankruptcy Court, Central District of California.
  3. Court decisions and orders related to the case, available from the PACER system.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.